Clinical outcomes and germline implications of primary KIT exon 13 and 17 mutations in gastrointestinal stromal tumors.
- DOI
- 10.1007/s10120-026-01810-2
- Published
- 2026 Oct 21
- Container
- Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10120-026-01810-2,
title = {Clinical outcomes and germline implications of primary KIT exon 13 and 17 mutations in gastrointestinal stromal tumors.},
author = {Hyung J and Kim HD and Jang E and Ma J and Park YS and Ryu MH},
year = {2026},
journal = {Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association},
doi = {10.1007/s10120-026-01810-2},
url = {https://doi.org/10.1007/s10120-026-01810-2}
}RIS
TY - JOUR TI - Clinical outcomes and germline implications of primary KIT exon 13 and 17 mutations in gastrointestinal stromal tumors. AU - Hyung J AU - Kim HD AU - Jang E AU - Ma J AU - Park YS AU - Ryu MH PY - 2026 JO - Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association DO - 10.1007/s10120-026-01810-2 UR - https://doi.org/10.1007/s10120-026-01810-2 ER -
APA
J, H., HD, K., E, J., J, M., YS, P., & MH, R. (2026). Clinical outcomes and germline implications of primary KIT exon 13 and 17 mutations in gastrointestinal stromal tumors.. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. https://doi.org/10.1007/s10120-026-01810-2
Source records
- pubmed · retrieved 2026-11-10T14:58:41.276Z